CD4 and metabolic disease: LSM >12.5 kPa at any time remained associated with an increased risk of liver-related mortality (aHR = 20.60 [5.99–70.78], p<0,001) after adjustment for sex, alcohol use, metabolic disorders, CD4+ level and previous HCV treatment.